Head-to-head · WeighScore
Belle Health vs Semaglutide Online
The verdict
Belle Health takes it — 77/100 to 74.3/100.
Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Belle Health | Semaglutide Online |
|---|---|---|
| WeighScore | 77/100 | 74.3/100 |
| Grade | C+ | C |
| Scorecard rank | #48 | #64 |
| Semaglutide | $119/mo | $199/mo (all doses, compounded) |
| Tirzepatide | $199/mo (all doses, 3-month plan, compounded) | $299/mo (all doses, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #48 · C+
Strengths
- Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
- Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
- Free weekly registered-dietitian sessions included
- Operating since 2017
- LegitScript Certified
Where it loses points
- $199 tirzepatide price requires a 3-month bundle commitment
- Compounded medications are not FDA-approved
- Multi-pharmacy model — formulations may differ across orders
- FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Graded #64 · C
Strengths
- LegitScript certified — passes accreditation standards recognized by Google and Visa for online telehealth
- Compounded all-in pricing: semaglutide $199/mo and tirzepatide $299/mo includes medication, provider care, and shipping
- Brand-name options (Wegovy pill, injectable sema, Zepbound) available for eligible patients, potentially $0-$25/mo with insurance
- Nationwide (49 states + DC); no appointment required, licensed provider reviews intake within 12 hours
- 0% financing through Credee from $79/month (12-24 months) plus Affirm and Klarna with ~97% approval rate
Where it loses points
- No labs or clinical monitoring disclosed — blood work requirements not mentioned anywhere on site
- Leadership team and medical director not identified on site — no named prescribers or company founders published
- Brand-name prescriptions add a $44/month provider fee on top of medication cost, raising total price to $193-$343/mo
- No coaching, dietitian, or behavioral support at any tier — medication and async provider access only
- 30-day satisfaction guarantee covers evaluation fee only; medication costs explicitly non-refundable
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.